BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19098605)

  • 1. Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain.
    Castellsagué X; Rémy V; Puig-Tintoré LM; de la Cuesta RS; Gonzalez-Rojas N; Cohet C
    J Low Genit Tract Dis; 2009 Jan; 13(1):38-45. PubMed ID: 19098605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
    Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
    Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of screening and treatment of cervical dyskaryosis in Germany.
    Petry KU; Breugelmans JG; Bénard S; Lamure E; Littlewood KJ; Hillemanns P
    Eur J Gynaecol Oncol; 2008; 29(4):345-9. PubMed ID: 18714567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy.
    Giorgi Rossi P; Ricciardi A; Cohet C; Palazzo F; Furnari G; Valle S; Largeron N; Federici A
    BMC Public Health; 2009 Feb; 9():71. PubMed ID: 19243586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain.
    Blade A; Cararach M; Castro M; Catalá-López F; Pérez-Escolano I; de Sanjosé S
    J Low Genit Tract Dis; 2010 Oct; 14(4):311-8. PubMed ID: 20885158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
    Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
    Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
    Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
    Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Pap smear' for screening of precancerous conditions of cervix.
    Noreen R; Qudussi H
    J Ayub Med Coll Abbottabad; 2011; 23(2):41-4. PubMed ID: 24800339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
    Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of precancerous cervical lesions in iran: a cost minimizing study.
    Nahvijou A; Sari AA; Zendehdel K; Marnani AB
    Asian Pac J Cancer Prev; 2014; 15(19):8209-13. PubMed ID: 25339007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
    CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
    Huitron S; Bonvicino A; Fadare O
    Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
    Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
    Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.